Sales & Earnings In Brief
This article was originally published in The Rose Sheet
Executive Summary
Beiersdorf “Not Satisfied” With 2010
You may also be interested in...
Analyst: Outsider Heidenreich Brings Fresh Perspective As Beiersdorf CEO
Beiersdorf AG’s surprise move to name Stefan F. Heidenreich CEO in place of Thomas-B. Quaas will give the firm a competitive boost, according to analyst Andrew Wood of Bernstein Research.
Outlook Is Cheery For Designer Fragrances This Holiday Season – NPD
This holiday season, designer fragrances are expected to compete more effectively against similarly priced electronics than they have in recent years, according to NPD Group Vice President and Global Industry Analyst Karen Grant.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”